Paul Treacy is VP at Jazz Pharmaceuticals plc (JAZZ). They have made 12 open-market trades across 1 company since 2015, most recently 2019-08-12.
CIK 0001232524
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JAZZ | 16,418 | $3.9M |
Shares reported on the most recent Form 4, priced at the 2019-08-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2019-08-12 | 2019-08-14 | $137.40 | $1.2M | -3.2% | -1.4% | -0.7% |
| JAZZ | SELL | 2019-03-06 | 2019-03-07 | $135.41 | $287K | +0.7% | +6.6% | -3.1% |
| JAZZ | SELL | 2019-03-01 | 2019-03-04 | $139.50 | $195K | +0.2% | +4.0% | -5.5% |
| JAZZ | SELL | 2018-08-10 | 2018-08-13 | $176.61 | $462K | -3.5% | -5.6% | -15.5% |
| JAZZ | SELL | 2018-03-06 | 2018-03-07 | $141.47 | $168K | +7.8% | +2.8% | +18.3% |
| JAZZ | SELL | 2018-03-02 | 2018-03-05 | $139.62 | $196K | +4.0% | +5.0% | +20.3% |
| JAZZ | SELL | 2017-08-14 | 2017-08-15 | $143.31 | $345K | -0.6% | +2.6% | -7.1% |
| JAZZ | SELL | 2017-03-06 | 2017-03-08 | $131.97 | $186K | +8.7% | +16.0% | +9.5% |
| JAZZ | SELL | 2016-08-16 | 2016-08-18 | $137.47 | $177K | -7.2% | -7.2% | -18.0% |
| JAZZ | SELL | 2016-08-16 | 2016-08-18 | $137.47 | $355K | -7.2% | -7.2% | -18.0% |
| JAZZ | SELL | 2016-02-29 | 2016-03-02 | $123.48 | $44K | +4.1% | +7.1% | +21.3% |
| JAZZ | SELL | 2015-08-11 | 2015-08-11 | $177.82 | $236K | -10.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.